Cargando…

Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device

Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumida, Iori, Yamaguchi, Hajime, Das, Indra J., Kizaki, Hisao, Aboshi, Keiko, Tsujii, Mari, Yamada, Yuji, Suzuki, Osamu, Seo, Yuji, Isohashi, Fumiaki, Ogawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690227/
https://www.ncbi.nlm.nih.gov/pubmed/26894363
http://dx.doi.org/10.1120/jacmp.v17i1.5899
_version_ 1783279560049033216
author Sumida, Iori
Yamaguchi, Hajime
Das, Indra J.
Kizaki, Hisao
Aboshi, Keiko
Tsujii, Mari
Yamada, Yuji
Suzuki, Osamu
Seo, Yuji
Isohashi, Fumiaki
Ogawa, Kazuhiko
author_facet Sumida, Iori
Yamaguchi, Hajime
Das, Indra J.
Kizaki, Hisao
Aboshi, Keiko
Tsujii, Mari
Yamada, Yuji
Suzuki, Osamu
Seo, Yuji
Isohashi, Fumiaki
Ogawa, Kazuhiko
author_sort Sumida, Iori
collection PubMed
description Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence deconvolved from the electronic portal imaging device (EPID) images. This method is validated for 10 head and neck IMRT cases. The fluence map of each beam was exported from the TPS and EPID images of the treatment beams were acquired. Measured EPID images were deconvolved to the incident fluence with proper corrections. The relative error distribution between the TPS fluence map and the incident fluence from the EPID was created. This was also created for a 2D diode array detector. The absolute point dose was measured with an ionization chamber, and the dose distribution was measured by a radiochromic film. In three cases, MLC leaf positions were intentionally changed to create the dose error as much as 5% against the planned dose and our fluence‐based method was tested using gamma index. Absolute errors between the predicted dose of 2D diode detector and of our method and measurements were [Formula: see text] and [Formula: see text] respectively. The gamma passing rate (3% global / 3 mm) of the TPS was higher than that of the 2D diode detector ([Formula: see text]), and lower than that of the EPID ([Formula: see text]). The gamma passing rate (2% global / 2 mm) of the TPS was higher than that of the 2D diode detector, while the gamma passing rate of the TPS was lower than that of EPID ([Formula: see text]). For three modified plans, the predicted dose errors against the measured dose were 1.10%, 2.14%, and [Formula: see text]. The predicted dose distributions from the EPID were well matched to the measurements. Our fluence‐based method provides very accurate dosimetry for IMRT patients. The method is simple and can be adapted to any clinic for complex cases. PACS numbers: 87.55.D‐, 87.55.km, 87.55.Qr, 87.57.uq
format Online
Article
Text
id pubmed-5690227
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56902272018-04-02 Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device Sumida, Iori Yamaguchi, Hajime Das, Indra J. Kizaki, Hisao Aboshi, Keiko Tsujii, Mari Yamada, Yuji Suzuki, Osamu Seo, Yuji Isohashi, Fumiaki Ogawa, Kazuhiko J Appl Clin Med Phys Radiation Oncology Physics Patient‐specific quality assurance for intensity‐modulated radiation therapy (IMRT) dose verification is essential. The aim of this study is to provide a new method based on the relative error distribution by comparing the fluence map from the treatment planning system (TPS) and the incident fluence deconvolved from the electronic portal imaging device (EPID) images. This method is validated for 10 head and neck IMRT cases. The fluence map of each beam was exported from the TPS and EPID images of the treatment beams were acquired. Measured EPID images were deconvolved to the incident fluence with proper corrections. The relative error distribution between the TPS fluence map and the incident fluence from the EPID was created. This was also created for a 2D diode array detector. The absolute point dose was measured with an ionization chamber, and the dose distribution was measured by a radiochromic film. In three cases, MLC leaf positions were intentionally changed to create the dose error as much as 5% against the planned dose and our fluence‐based method was tested using gamma index. Absolute errors between the predicted dose of 2D diode detector and of our method and measurements were [Formula: see text] and [Formula: see text] respectively. The gamma passing rate (3% global / 3 mm) of the TPS was higher than that of the 2D diode detector ([Formula: see text]), and lower than that of the EPID ([Formula: see text]). The gamma passing rate (2% global / 2 mm) of the TPS was higher than that of the 2D diode detector, while the gamma passing rate of the TPS was lower than that of EPID ([Formula: see text]). For three modified plans, the predicted dose errors against the measured dose were 1.10%, 2.14%, and [Formula: see text]. The predicted dose distributions from the EPID were well matched to the measurements. Our fluence‐based method provides very accurate dosimetry for IMRT patients. The method is simple and can be adapted to any clinic for complex cases. PACS numbers: 87.55.D‐, 87.55.km, 87.55.Qr, 87.57.uq John Wiley and Sons Inc. 2016-01-08 /pmc/articles/PMC5690227/ /pubmed/26894363 http://dx.doi.org/10.1120/jacmp.v17i1.5899 Text en © 2016 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Sumida, Iori
Yamaguchi, Hajime
Das, Indra J.
Kizaki, Hisao
Aboshi, Keiko
Tsujii, Mari
Yamada, Yuji
Suzuki, Osamu
Seo, Yuji
Isohashi, Fumiaki
Ogawa, Kazuhiko
Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title_full Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title_fullStr Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title_full_unstemmed Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title_short Intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
title_sort intensity‐modulated radiation therapy dose verification using fluence and portal imaging device
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690227/
https://www.ncbi.nlm.nih.gov/pubmed/26894363
http://dx.doi.org/10.1120/jacmp.v17i1.5899
work_keys_str_mv AT sumidaiori intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT yamaguchihajime intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT dasindraj intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT kizakihisao intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT aboshikeiko intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT tsujiimari intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT yamadayuji intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT suzukiosamu intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT seoyuji intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT isohashifumiaki intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice
AT ogawakazuhiko intensitymodulatedradiationtherapydoseverificationusingfluenceandportalimagingdevice